Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism

Comparison Between the New Gore Septal and Amplatzer Devices For Transcatheter Closure of Patent Foramen Ovale

“…13 In the present series, only 3 patients in the GSO group had a PFO with ASA, therefore the safety and efficacy of this device should be tested in large studies including more patients with a PFO associated with ASA. 14 We did not find any case of GSO wire frame fracture but it should be noted that fractures with the GORE HELEX Septal Occluder were mainly associated with larger devices. 15 GSO devices were easily implanted.…”

Management of residual shunts after initial percutaneous patent foramen ovale closure: A single center experience with immediate and long‐term follow‐up

“…Although successful closure is typically the norm, in a minority of patients, incomplete closure may result in persistent residual shunting [20][21][22][23]. The clinical importance of these residual shunts have been previously elucidated in stroke victims [7,8].…”

Temporal healing patterns and coverage dynamics after new Polish transcatheter PFO occluder implantation in a swine

“…Complications after transcatheter PFO closure are rare; nevertheless, they occur and may cause death or neurological deficits [6]. The delayed neointimal coverage, impaired endothelialisation, and persistent inflammation in the nitinol--based devices could play a role in suboptimal long-term results after transcatheter PFO closure by leading to thromboembolic events, including ischaemic stroke.…”